Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

Clinical trial NCT00960310 · COMPLETED

Trial details

NCT number: NCT00960310
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Hirsutism

Start date: 2006-06-01
Primary completion: 2006-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.